Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Methods × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 46 Neoplasms 36 Colorectal Neoplasms 23 Lung Neoplasms 22 Prostatic Neoplasms 15 Uterine Cervical Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Lymphoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 4 Papillomavirus Infections 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4

Interventions

Sorafenib 203 lenvatinib 129 Bevacizumab 106 Nivolumab 75 atezolizumab 67 pembrolizumab 66 Radiosurgery 58 durvalumab 57 Oxaliplatin 54 Fluorouracil 52 sintilimab 48 Doxorubicin 43 apatinib 41 Hepatectomy 39 tislelizumab 38 camrelizumab 37 Radiofrequency Ablation 36 Leucovorin 36 tremelimumab 34 Radiotherapy 34 Magnetic Resonance Spectroscopy 31 Immune Checkpoint Inhibitors 27 Folfox protocol 26 regorafenib 25 Cyclophosphamide 25 Cisplatin 25 Capecitabine 25 cabozantinib 23 Ipilimumab 23 Gemcitabine 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07120750 2025-08-13

PRTRAS 001

Shenzhen Third People's Hospital

Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡